[{"data":1,"prerenderedAt":48},["ShallowReactive",2],{"q-nurse-111-1-basic-medicine-052":3},{"subject":4,"subjectSlug":5,"subjectFullName":6,"question":7,"related":23},"基礎醫學","basic-medicine","基礎醫學(包括解剖學、生理學、病理學、藥理學、微生物學與免疫學)",{"id":8,"webId":9,"year":10,"session":11,"subject":4,"number":12,"stem":13,"options":14,"answer":19,"answerNote":20,"images":21,"explanation":22,"freq":11},"nurse-111-1-基礎醫學-052","nurse-111-1-basic-medicine-052",111,1,52,"下列藥物中，何者不適用於治療生長激素分泌過多而產生的肢端肥大症？",{"A":15,"B":16,"C":17,"D":18},"Octreotide","Bromocriptine","Corticotropin","Pegvisomant","C",null,[],"本題考點為肢端肥大症（生長激素過多）的藥物治療，須選不適用者。Corticotropin（ACTH）是刺激腎上腺皮質分泌皮質醇的促腎上腺皮質激素，與抑制生長激素無關，反而屬刺激性荷爾蒙，故不適用，選 C。A 的 Octreotide 是體抑素（somatostatin）類似物，可抑制 GH 分泌，為第一線用藥。B 的 Bromocriptine 是多巴胺致效劑，可抑制部分 GH 分泌腺瘤的分泌。D 的 Pegvisomant 是生長激素受體拮抗劑，阻斷 GH 在周邊作用、降低 IGF-1。三者皆為治療肢端肥大症的正確方向，唯 C 反向。",[24,28,32,36,40,44],{"webId":25,"stem":26,"number":11,"year":27,"session":11},"nurse-106-1-basic-medicine-001","下列有關表皮的敘述，何者正確？",106,{"webId":29,"stem":30,"number":31,"year":27,"session":11},"nurse-106-1-basic-medicine-002","下列何者在組織學特徵上可區分為絲球帶（zona glomerulosa）、束狀帶（zona fasciculata）、網狀帶（zona reticularis）？",2,{"webId":33,"stem":34,"number":35,"year":27,"session":11},"nurse-106-1-basic-medicine-003","顴弓（zygomatic arch）是由顴骨與下列何者共同組成？",3,{"webId":37,"stem":38,"number":39,"year":27,"session":11},"nurse-106-1-basic-medicine-004","下列何者參與形成踝關節？",4,{"webId":41,"stem":42,"number":43,"year":27,"session":11},"nurse-106-1-basic-medicine-005","下列何者是維持背部直立最重要的肌肉？",5,{"webId":45,"stem":46,"number":47,"year":27,"session":11},"nurse-106-1-basic-medicine-006","行走於前臂的內側，並與上臂深層的靜脈會合成腋靜脈的是那一條血管？",6,1783840768497]